hASCs were systemically administered in the DMD mouse (mdx) and dog (GRMD) models and were shown to be well-tolerated, with good muscle engraftment and some human dystrophin expression (Rodriguez et al., 2005; Vieira et al., 2012; Pelatti et al., 2016). Here, DMD is linked to Duchenne muscular dystrophy.